Cns Pharmaceuticals, Inc.盘中异动股价大跌5.46%报0.118美元

市场透视11-14

北京时间2024年11月14日22时44分，Cns Pharmaceuticals, Inc.（CNSP.us）股票出现异动，股价快速下跌5.46%。截至发稿，该股报0.118美元/股，成交量108.899万股，换手率2.67%，振幅4.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.53百万美元，每股收益-6.72美元，毛利-752.00美元，市盈率-0.00倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2483043388?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-14 22:44","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2483043388","market":"us","top_or_hot":-1,"title":"Cns Pharmaceuticals, Inc.盘中异动 股价大跌5.46%报0.118美元","media":"市场透视","content":"<div>\n<p>北京时间2024年11月14日22时44分，Cns Pharmaceuticals, Inc.（CNSP.us）股票出现异动，股价快速下跌5.46%。截至发稿，该股报0.118美元/股，成交量108.899万股，换手率2.67%，振幅4.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.53百万美元，每股收益-6.72美元，毛利-752.00美元，市盈率-0.00倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422445798e42a73&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cns Pharmaceuticals, Inc.盘中异动 股价大跌5.46%报0.118美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCns Pharmaceuticals, Inc.盘中异动 股价大跌5.46%报0.118美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 22:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422445798e42a73&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月14日22时44分，Cns Pharmaceuticals, Inc.（CNSP.us）股票出现异动，股价快速下跌5.46%。截至发稿，该股报0.118美元/股，成交量108.899万股，换手率2.67%，振幅4.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.53百万美元，每股收益-6.72美元，毛利-752.00美元，市盈率-0.00倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422445798e42a73&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CNSP","symbol_name":"CNS Pharmaceuticals, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422445798e42a73&s=b","article_id":"2483043388","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422445798e42a73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2483043388","pubTimestamp":1731595497,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月14日22时44分，Cns Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.46%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CNSP":"CNS Pharmaceuticals, Inc.","BK4007":"制药","BK4183":"个人用品","ELAB":"Elevai Labs, Inc."},"translate_title":"Cns Pharmaceuticals, Inc. shares fell 5.46% to $0.118 during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNSP":0.9,"ELAB":0.86},"content_text":"北京时间2024年11月14日22时44分，Cns Pharmaceuticals, Inc.（CNSP.us）股票出现异动，股价快速下跌5.46%。截至发稿，该股报0.118美元/股，成交量108.899万股，换手率2.67%，振幅4.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.53百万美元，每股收益-6.72美元，毛利-752.00美元，市盈率-0.00倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts (01/12/2026) To Pur Com涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1837.51%、26.77%、18.49%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Pulmatrix, Inc.、Elevai Labs, Inc.，振幅分别为75.00%、38.76%、38.46%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。 该公司参与了 Berubicin 的开发，它是一种治疗胶质母细胞瘤的疗法。 胶质母细胞瘤是由星形胶质细胞产生的肿瘤，而星形胶质细胞是构成大脑支持组织的星形细胞。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483043388"}

Cns Pharmaceuticals, Inc.盘中异动 股价大跌5.46%报0.118美元

精彩评论

Cns Pharmaceuticals, Inc.盘中异动股价大跌5.46%报0.118美元